These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
446 related items for PubMed ID: 19383907
1. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Zucchetto A, Benedetti D, Tripodo C, Bomben R, Dal Bo M, Marconi D, Bossi F, Lorenzon D, Degan M, Rossi FM, Rossi D, Bulian P, Franco V, Del Poeta G, Deaglio S, Gaidano G, Tedesco F, Malavasi F, Gattei V. Cancer Res; 2009 May 01; 69(9):4001-9. PubMed ID: 19383907 [Abstract] [Full Text] [Related]
2. Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells. Zucchetto A, Tripodo C, Benedetti D, Deaglio S, Gaidano G, Del Poeta G, Gattei V. Br J Haematol; 2010 Jul 01; 150(1):111-3. PubMed ID: 20346010 [No Abstract] [Full Text] [Related]
3. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Ibrahim S, Jilani I, O'Brien S, Rogers A, Manshouri T, Giles F, Faderl S, Thomas D, Kantarjian H, Keating M, Albitar M. Cancer; 2003 Apr 15; 97(8):1914-9. PubMed ID: 12673718 [Abstract] [Full Text] [Related]
4. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells. Zucchetto A, Vaisitti T, Benedetti D, Tissino E, Bertagnolo V, Rossi D, Bomben R, Dal Bo M, Del Principe MI, Gorgone A, Pozzato G, Gaidano G, Del Poeta G, Malavasi F, Deaglio S, Gattei V. Leukemia; 2012 Jun 15; 26(6):1301-12. PubMed ID: 22289918 [Abstract] [Full Text] [Related]
5. Interaction with vascular endothelium enhances survival in primary chronic lymphocytic leukemia cells via NF-kappaB activation and de novo gene transcription. Buggins AG, Pepper C, Patten PE, Hewamana S, Gohil S, Moorhead J, Folarin N, Yallop D, Thomas NS, Mufti GJ, Fegan C, Devereux S. Cancer Res; 2010 Oct 01; 70(19):7523-33. PubMed ID: 20736369 [Abstract] [Full Text] [Related]
10. High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia. Nückel H, Switala M, Collins CH, Sellmann L, Grosse-Wilde H, Dührsen U, Rebmann V. Clin Immunol; 2009 Jun 01; 131(3):472-80. PubMed ID: 19318232 [Abstract] [Full Text] [Related]
11. Variable expression of CD49d antigen in B cell chronic lymphocytic leukemia is related to disease stages. Eksioğlu-Demiralp E, Alpdoğan O, Aktan M, Firatli T, Oztürk A, Budak T, Bayik M, Akoğlu T. Leukemia; 1996 Aug 01; 10(8):1331-9. PubMed ID: 8709639 [Abstract] [Full Text] [Related]
12. CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells. Deaglio S, Vaisitti T, Zucchetto A, Gattei V, Malavasi F. Semin Cancer Biol; 2010 Dec 01; 20(6):416-23. PubMed ID: 20817095 [Abstract] [Full Text] [Related]
13. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4. Willimott S, Baou M, Huf S, Deaglio S, Wagner SD. Haematologica; 2007 Oct 01; 92(10):1359-66. PubMed ID: 18024373 [Abstract] [Full Text] [Related]
14. T-cell CD38 expression in B-chronic lymphocytic leukaemia. Abousamra NK, El-Din MS, Azmy E. Hematol Oncol; 2009 Jun 01; 27(2):82-9. PubMed ID: 19247976 [Abstract] [Full Text] [Related]
15. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue. Duan H, Cheng L, Sun X, Wu Y, Hu L, Wang J, Zhao H, Lu G. Thromb Haemost; 2006 Dec 01; 96(6):807-15. PubMed ID: 17139377 [Abstract] [Full Text] [Related]
16. Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9. Buggins AG, Levi A, Gohil S, Fishlock K, Patten PE, Calle Y, Yallop D, Devereux S. Br J Haematol; 2011 Jul 01; 154(2):216-22. PubMed ID: 21569005 [Abstract] [Full Text] [Related]
17. CD31 density is a novel risk factor for patients with B-cell chronic lymphocytic leukaemia. Mainou-Fowler T, Porteous A, Nicolle A, Proctor SJ, Anderson JJ, Summerfield G. Int J Oncol; 2008 Jul 01; 33(1):169-74. PubMed ID: 18575763 [Abstract] [Full Text] [Related]
18. In contrast to high CD49d, low CXCR4 expression indicates the dependency of chronic lymphocytic leukemia (CLL) cells on the microenvironment. Kriston C, Plander M, Márk Á, Sebestyén A, Bugyik E, Matolcsy A, Barna G. Ann Hematol; 2018 Nov 01; 97(11):2145-2152. PubMed ID: 29955944 [Abstract] [Full Text] [Related]
19. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells. Tanaka Y, Mine S, Hanagiri T, Hiraga T, Morimoto I, Figdor CG, van Kooyk Y, Ozawa H, Nakamura T, Yasumoto K, Eto S. Cancer Res; 1998 Sep 15; 58(18):4138-45. PubMed ID: 9751626 [Abstract] [Full Text] [Related]
20. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia. Joshi AD, Hegde GV, Dickinson JD, Mittal AK, Lynch JC, Eudy JD, Armitage JO, Bierman PJ, Bociek RG, Devetten MP, Vose JM, Joshi SS. Clin Cancer Res; 2007 Sep 15; 13(18 Pt 1):5295-304. PubMed ID: 17875758 [Abstract] [Full Text] [Related] Page: [Next] [New Search]